Health

Current Picks

Delhi Traffic Police Spirometry Tests Reveal COPD Among Auto-Rickshaw Drivers

By Esther Okello / Jun 8, 2026

Delhi traffic police spirometry camps screen auto-rickshaw drivers for COPD, revealing undiagnosed lung obstruction. The program highlights disparities in respiratory care across wealth levels.

Tuberculosis Drug Resistance Debate Splits Global Health Experts on Dosing Regimens

By Esther Okello / Jun 8, 2026

Global health experts are divided over tuberculosis dosing regimens as shorter courses show promise but raise relapse risks in high-burden settings. This feature examines the evidence and country-level decisions.

Metformin Supply Shortages Push Kenyan Clinics to Sulphonylurea First-Line Therapy

By Min Park / Jun 9, 2026

Persistent metformin supply gaps in Kenya are forcing clinicians to switch to sulphonylureas as first-line therapy, raising hypoglycemia risks and reigniting debate over pragmatic vs. evidence-based care.

Private Insurer Prior Authorization Blocks Sepsis Rapid-Response Protocols in US Hospitals

By Elena Vargas / Jun 8, 2026

Prior authorization by private insurers delays life-saving sepsis protocols in US hospitals, contributing to avoidable deaths. This feature examines the bottleneck, hospital countermeasures, and policy gaps.

UK Children with Asthma Wait Months for Specialist Reviews While Private Clinics Offer Same-Day Access

By Min Park / Jun 9, 2026

NHS paediatric asthma review backlogs force children to wait 6–12 months for specialists, while private clinics offer same-day access. This gap worsens outcomes and deepens health inequality.

Uganda Health Workers Prescribe Diazepam for Alcohol Withdrawal Despite Evidence-Based Protocols

By Esther Okello / Jun 8, 2026

In Uganda, clinicians routinely prescribe diazepam for alcohol withdrawal despite WHO guidelines favoring chlordiazepoxide. This gap between evidence and practice reflects supply chain realities and has real consequences for patient safety.

Atrial Fibrillation Patients in Rural Uganda Wait Months for First ECG

By Elena Vargas / Jun 8, 2026

In rural Uganda, patients with atrial fibrillation wait months for an ECG, raising stroke risk. Handheld devices and community health workers offer a path forward, but funding gaps persist.

Thyroid Overdiagnosis Debate Intensifies as US Thyroid Cancer Incidence Triples

By Min Park / Jun 8, 2026

US thyroid cancer incidence has tripled since 1975, yet mortality remains flat. Experts clash over whether screening causes net harm through overdiagnosis of indolent tumors.

US Spirometry Rates for COPD Diagnosis Stall at Forty Percent of Primary Care Visits

By Elena Vargas / Jun 8, 2026

Despite guidelines, spirometry use in US primary care for COPD diagnosis hovers near 40%. This feature examines barriers, evidence gaps, and policy roadblocks.

US COPD Readmission Penalties Push Hospitals to Overuse Short-Acting Inhalers

By Min Park / Jun 8, 2026

US hospital readmission penalties intended to improve COPD care inadvertently drive overprescription of short-acting inhalers, undermining long-term outcomes.

Bangladesh Floating Clinics Cut Stillbirths as Monsoon Floods Close Rural Roads

By Elena Vargas / Jun 9, 2026

In flood-prone Bangladesh, floating clinics provide antenatal care to pregnant women cut off by monsoon floods. A 2024 study found a 30% lower stillbirth rate among users compared to road-based facilities.

US Medicare Part D Premium Caps Cut Atrial Fibrillation Drug Costs But Not for All Patients

By Min Park / Jun 8, 2026

Medicare Part D premium caps reduce out-of-pocket costs for DOACs in atrial fibrillation, but gaps remain for warfarin users, racial minorities, and those facing formulary barriers.

US Polyp Detection Medicare Reimbursement Lags Behind AI-Assisted Colonoscopy Trial Data

By Elena Vargas / Jun 8, 2026

AI-assisted colonoscopy boosts adenoma detection by 20–30% in trials, but Medicare reimbursement codes haven't changed since 2021. This gap slows adoption in community practices.

Kenya Diabetes Drug Supply Deals Favor Branded Insulin Over Cheaper Biosimilars

By Esther Okello / Jun 8, 2026

Kenya's public insulin procurement favors expensive branded products over cheaper biosimilars, costing millions in potential savings and limiting access for diabetes patients.

UK Prior Authorization Rules for Biosimilar Adalimumab Delay First-Line Psoriasis Care

By Min Park / Jun 8, 2026

UK prior authorization for biosimilar adalimumab delays first-line psoriasis treatment, with step therapy requirements and administrative burdens worsening patient outcomes despite NICE guidance.

US Physician Assistant Scope-of-Practice Laws Block Evidence-Based Primary Care Access

By Raphael Andriamanjato / Jun 8, 2026

State-by-state physician assistant scope-of-practice restrictions limit primary care access despite evidence of safe, effective PA-led care. Reform could reduce wait times and improve health equity.

UK Antidepressant Discontinuation Guidance Splits GPs on Tapering Duration

By Min Park / Jun 8, 2026

NICE's 2024 draft guidance recommending 4-week antidepressant tapering faces pushback from GPs who say it's unrealistic. Evidence gaps, training deficits, and medico-legal fears complicate care.

Rwanda Cervical Cancer Self-Sampling Kits Boost Screening Among Rural Women

By Esther Okello / Jun 9, 2026

Rwanda's HPV self-sampling kits are overcoming barriers to cervical cancer screening for rural women, with high uptake and accuracy in pilot programs. The Ministry of Health plans to scale to 100,000 women by 2027.

UK NHS IAPT Mental Health Targets Miss Patients with Long-Term Conditions

By Esther Okello / Jun 8, 2026

NHS IAPT mental health targets inadvertently exclude patients with long-term physical conditions like diabetes and arthritis, perverse incentives skew care away from complex cases.

UK NICE Rejects Triple Therapy Inhaler for Mild Asthma Despite Trial Data

By Min Park / Jun 8, 2026

NICE has rejected a single-inhaler triple therapy for mild asthma, citing cost concerns despite trial data showing reduced exacerbations. Experts are divided on whether the decision prioritises population health over individual need.